Infectious Diseases News and Research

RSS

Preventive antibiotics for HIV patients lower risk of TB or death

As part of the largest international research effort ever made to combat tuberculosis, a team of Johns Hopkins and Brazilian experts has found that preventive antibiotic therapy for people with HIV lowers this group's chances of developing TB or dying.

16 Aug 2013

Boehringer Ingelheim completes patient enrolment of two pivotal Phase III interferon-free hepatitis C clinical trials

Boehringer Ingelheim today announced that enrolment of over 950 treatment naïve genotype-1b patients in the pivotal Phase III interferon-free HCVerso™ 1 and 2 trials is complete.

15 Aug 2013

Viewpoints: Gov. Jindal skeptical of navigators program; scare tactics against Obamacare growing

By August 15, the Obama administration is expected to spend $54 million of our tax dollars to hire community organizers to push this law on the American people. ...

14 Aug 2013

A*STAR's SIgN discovers new strategy to develop universal dengue vaccine

A new strategy that cripples the ability of the dengue virus to escape the host immune system has been discovered by A*STAR's Singapore Immunology Network. This breakthrough strategy opens a door of hope to what may become the world's first universal dengue vaccine candidate that can give full protection from all four serotypes of the dreadful virus.

14 Aug 2013

SIgN discovers strategy that cripples ability of dengue virus to escape host immune system

A new strategy that cripples the ability of the dengue virus to escape the host immune system has been discovered by A*STAR's Singapore Immunology Network (SIgN). This breakthrough strategy opens a door of hope to what may become the world's first universal dengue vaccine candidate that can give full protection from all four serotypes of the dreadful virus.

14 Aug 2013

Characterizing stem cells in larval schistosomes may help control prolific human parasite

Ancient Egyptian mummies revealed that humans have been hosting parasitic flatworms called schistosomes for more than 5,000 years. Today these parasites continue to plague millions of people across the world, causing roughly 250,000 deaths each year.

13 Aug 2013

Viewpoints: Obama overlooking legal constraints on employer mandate delay; Bush's 'unnecessary' heart procedure; discrimination against people with mental illnesses

In his Friday remarks, Mr. Obama also claimed that he had the "executive authority" for the mandate delay. But if he really believes that, then why did he say he would normally ask for a legislative "tweak." Either the fix requires legislation or it doesn't. His comments are certainly revealing about his attitudes on Presidential power and the constraints of the U.S. Constitution. Article II, Section 3 instructs him to take care that the laws be faithfully executed, not merely what he thinks is "the essence" of laws (8/10).

13 Aug 2013

Study highlights challenges of predicting disease outcomes in warming world

Climate change is already affecting the spread of infectious diseases--and human health and biodiversity worldwide--according to disease ecologists reporting research results in this week's issue of the journal Science.

13 Aug 2013

Strategy that dismantles flu viral genome in human lung cells ensures safe research

A new strategy that dismantles a viral genome in human lung cells will ensure safe research on deadly strains of influenza, say researchers from the Icahn School of Medicine at Mount Sinai.

13 Aug 2013

Researchers identify first disease gene for idiopathic focal epilepsy in childhood

More than 50 million people worldwide have epilepsy, with a third of these being children. The most common forms of epilepsy in children occur without any apparent trigger and only affect certain regions of the brain.

12 Aug 2013

Researchers identify biomarkers of TB that may help in new treatments

Researchers at the University of Southampton have identified new markers of tuberculosis (TB) that may help in the development of new diagnostic tests and treatments.

12 Aug 2013

Researchers find antibodies specific to MERS-CoV in dromedary camels

Researchers searching for signs of Middle East respiratory syndrome coronavirus in livestock animals have found antibodies specific to the new virus in dromedary camels. The research, published in The Lancet Infectious Diseases, suggests that these animals have encountered MERS-CoV, or a closely related virus, and may be one reservoir of the virus that is causing MERS in humans.

9 Aug 2013

GE, UW scientists to develop new medical device for detecting infectious disease

You've heard of on-demand TV, now imagine on-demand medical diagnosis - anytime, anywhere in the world. Scientists at GE Global Research, the technology development arm of the General Electric Co. (NYSE: GE), are working with a team based at the University of Washington to develop a new medical device, the size of a pack of playing cards, that can detect infectious disease by way of a simple nasal swab, in less than an hour.

9 Aug 2013

Phase I clinical trial: Sanaria PfSPZ Vaccine provides complete protection against malaria

Results of a phase I clinical trial of the Sanaria PfSPZ Vaccine to combat malaria, published today in the online issue of Science magazine, show that the vaccine provided complete protection against malaria in subjects who were exposed to Plasmodium falciparum parasites. Plasmodium falciparum is the malaria parasite that causes more than 600,000 deaths annually.

9 Aug 2013

Investigational malaria vaccine offers protection against malaria infection in healthy adults

An investigational malaria vaccine has been found to be safe, to generate an immune system response, and to offer protection against malaria infection in healthy adults, according to the results of an early-stage clinical trial published Aug. 8 in the journal Science.

9 Aug 2013

AmpliPhi releases data on phage therapy for treatment of lung infections in Cystic Fibrosis patients

AmpliPhi BioSciences Corp. (OTC: APHB) ("AmpliPhi"), the leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant bacterial infections, yesterday presented data relating to the use of bacteriophages in the treatment of Pseudomonas aeruginosa (P. aeruginosa) at the 20th Biennial Evergreen International Phage Meeting held in Olympia, Washington, USA. P. aeruginosa is the major cause of lung infections in cystic fibrosis (CF) patients.

8 Aug 2013

Teplizumab to block type 1 diabetes proves strikingly effective in phase 2 clinical trial

An experimental drug designed to block the advance of type 1 diabetes in its earliest stages has proven strikingly effective over two years in about half of the patients who participated in the phase 2 clinical trial.

8 Aug 2013

Scientist receives 1.3M grant to study how beneficial bacteria protect against deadly infection

A Norwich Research Park scientist has received -1.3 million in funding from the Wellcome Trust to investigate how beneficial bacteria protect against deadly infection in early life.

8 Aug 2013

Lupin acquires exclusive license to promote, distribute Romark's Alinia for Oral Suspension in US

Romark Laboratories announced that it has entered into a strategic agreement with Lupin Limited and its subsidiaries (collectively Lupin) designed to expand promotion and distribution efforts related to its Alinia (nitazoxanide) for Oral Suspension, 100 mg/5 mL. Under the agreement, Lupin acquired an exclusive license to promote and distribute Alinia for Oral Suspension in the United States.

7 Aug 2013

Scientists discover biomarker that helps physicians predict how well cancer patients respond to drugs

A team of scientists led by Associate Professor Zeng Qi from A*STAR's Institute of Molecular and Cell Biology (IMCB) have discovered a new biomarker which will help physicians predict how well cancer patients respond to cancer drugs.

7 Aug 2013

Infectious Diseases News and Research

Preventive antibiotics for HIV patients lower risk of TB or death

Boehringer Ingelheim completes patient enrolment of two pivotal Phase III interferon-free hepatitis C clinical trials

Viewpoints: Gov. Jindal skeptical of navigators program; scare tactics against Obamacare growing

A*STAR's SIgN discovers new strategy to develop universal dengue vaccine

SIgN discovers strategy that cripples ability of dengue virus to escape host immune system

Characterizing stem cells in larval schistosomes may help control prolific human parasite

Viewpoints: Obama overlooking legal constraints on employer mandate delay; Bush's 'unnecessary' heart procedure; discrimination against people with mental illnesses

Study highlights challenges of predicting disease outcomes in warming world

Strategy that dismantles flu viral genome in human lung cells ensures safe research

Researchers identify first disease gene for idiopathic focal epilepsy in childhood

Researchers identify biomarkers of TB that may help in new treatments

Researchers find antibodies specific to MERS-CoV in dromedary camels

GE, UW scientists to develop new medical device for detecting infectious disease

Phase I clinical trial: Sanaria PfSPZ Vaccine provides complete protection against malaria

Investigational malaria vaccine offers protection against malaria infection in healthy adults

AmpliPhi releases data on phage therapy for treatment of lung infections in Cystic Fibrosis patients

Teplizumab to block type 1 diabetes proves strikingly effective in phase 2 clinical trial

Scientist receives 1.3M grant to study how beneficial bacteria protect against deadly infection

Lupin acquires exclusive license to promote, distribute Romark's Alinia for Oral Suspension in US

Scientists discover biomarker that helps physicians predict how well cancer patients respond to drugs

eBook: Advancing infectious disease vaccine development eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News